Risks and benefits of diagnostic tests discussed by experts in Harvard TH Chan School of Public Health Forum – “Medical Tests: Inaccuracies, Risks and the Public’s Health”
December 11, 2015
SRP team publishes letter to the editor, “Cost-effectiveness of 70-gene signature versus AdjuvantOnline and systemic chemotherapy for risk stratification of patients with node-negative breat cancer. Does accuracy matter?”
April 6, 2015
SRP team to collaborate with Pacira, Inc around demonstrating utility and cost-effectiveness of pharmaceutical product
April 1, 2015
SRP in collaboration with SciMedCon LLC present their findings following a review of Kentucky’s Lung Cancer Research Program
June 25, 2014
SRP and Biogen, Inc. to collaborate on evaluating safety of several products in clinical trials
May 5, 2014